Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.8 -0.28 (-0.72%) Market Cap: 5.66 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 19.09 GF Score: 70/100

Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 03:30PM GMT
Release Date Price: $62.06 (-2.11%)
Jessica Macomber Fye
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. And we're continuing the 2020 Healthcare Conference this morning with Ionis. We're going to host a Q&A session with the management team right after this. It's just down the hall in the Olympic room. You can follow me down there if you're interested.

But for the presentation, I'm going to turn it over to the company's CEO, Brett Monia.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Good morning, everybody, and thank you for coming so early to this presentation. And thanks, Jess, for the introduction.

These are my forward-looking statements. I recommend them to you to review at your convenience.

These are indeed new days at Ionis Pharmaceuticals as I, Brett Monia, take on a new role at Ionis as the Chief Executive Officer, as Jess mentioned. It's a role that I'm incredibly excited about and very much looking forward to. And I'm confident

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot